Literature DB >> 30430557

Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients.

M Augustin1, R Sommer1, N Kirsten1, A Danckworth1, M A Radtke1, K Reich2, D Thaci3, W H Boehncke4, A Langenbruch1, U Mrowietz5.   

Abstract

BACKGROUND: Different phenotypes have been described in psoriasis. Few details are known about the topology of patients in routine care.
OBJECTIVES: To characterize the frequency and distribution of body sites affected by psoriasis in Germany.
METHODS: Data from a national cross-sectional study (PsoHealth2) were analysed. Each practice consecutively recruited 20 patients independently of treatment. Topical distribution was identified with a detailed grid scheme of 1424 squares filled by the patient. Psoriasis history, clinical findings, comorbidity and patient-reported outcomes were obtained.
RESULTS: In total, 2009 patients with psoriasis were observed. Nineteen per cent of patients had psoriatic arthritis, 65·4% had scalp involvement and 35·6% had nail involvement; in 40·5% of patients, their first-degree relatives also had psoriasis. In total, 1927 (95·9%) provided complete grid data. The mean number of grids marked was 152·4 ± 193·2, corresponding to 10·7% of body surface area. The most frequently affected body areas were the elbows, knees, lower legs and scalp (65-78%). In a linear regression analysis (corrected R² = 0·093), the strongest predictors of reductions in health-related quality of life (HRQoL), measured by the Dermatology Life Quality Index, were having the hands (β = 0·147; P = 0·000), arms (β = 0·097; P = 0·008), genitals (β = 0·080; P = 0·010), neck (β = -0·072; P = 0·043), scalp (β = 0·068; P = 0·010) and nails affected (β = 0·064; P = 0·005).
CONCLUSIONS: Typical psoriatic lesions are found in real-world care. However, smaller areas are important determinants of reductions in HRQoL.
© 2018 British Association of Dermatologists.

Entities:  

Year:  2019        PMID: 30430557     DOI: 10.1111/bjd.17403

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis.

Authors:  Marco Galluzzo; Marina Talamonti; Arnaldo Cioni; Virginia Maffei; Ruslana Gaeta Shumak; Lorenzo Tofani; Luca Bianchi; Elena Campione
Journal:  J Clin Med       Date:  2022-05-07       Impact factor: 4.964

2.  Prevalence of Tobacco Smoking and Its Association With Disease Severity Among Patients With Psoriasis in China: A Cross-Sectional Study.

Authors:  Lei Wei; Siting Chen; Zhan Zhang; Le Kuai; Rui Zhang; Ning Yu; Yuling Shi; Bin Li; Ruiping Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-12

3.  Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.

Authors:  Alexander Egeberg; Kyoungah See; Alyssa Garrelts; Russel Burge
Journal:  BMC Dermatol       Date:  2020-05-20

4.  Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care.

Authors:  Neuza da Silva; Matthias Augustin; Anna Langenbruch; Ulrich Mrowietz; Kristian Reich; Diamant Thaçi; Wolf-Henning Boehncke; Natalia Kirsten; Alexandra Danckworth; Rachel Sommer
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

5.  Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life.

Authors:  Dorota Purzycka-Bohdan; Anna Kisielnicka; Monika Zabłotna; Bogusław Nedoszytko; Roman J Nowicki; Adam Reich; Dominik Samotij; Justyna Szczęch; Dorota Krasowska; Joanna Bartosińska; Joanna Narbutt; Aleksandra Lesiak; Paulina Barasińska; Agnieszka Owczarczyk-Saczonek; Joanna Czerwińska; Jacek C Szepietowski; Aleksandra Batycka-Baran; Rafał Czajkowski; Magdalena Górecka-Sokołowska; Lidia Rudnicka; Joanna Czuwara; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

6.  A German Smartphone-Based Self-management Tool for Psoriasis: Community-Driven Development and Evaluation of Quality-of-Life Effects.

Authors:  Lea C Brandl; Claudia Liebram; Wendelin Schramm; Monika Pobiruchin
Journal:  JMIR Form Res       Date:  2022-07-07

7.  Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns - a cross-sectional study.

Authors:  Neuza da Silva; Matthias Augustin; Caroline Hilbring; Catharina C Braren-von Stülpnagel; Rachel Sommer
Journal:  BMJ Open       Date:  2022-09-23       Impact factor: 3.006

8.  Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method.

Authors:  Marie-Aleth Richard; François Aubin; Nathalie Beneton; Anne Bouloc; Anne-Claire Bursztejn; Vincent Descamps; Denis Jullien
Journal:  Adv Ther       Date:  2022-09-16       Impact factor: 4.070

9.  Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey.

Authors:  Hideshi Torii; Mitsumasa Kishimoto; Masayuki Tanaka; Hidehisa Noguchi; Siddharth Chaudhari
Journal:  J Dermatol       Date:  2022-05-27       Impact factor: 3.468

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.